Technical Analysis for SPRB - Spruce Biosciences, Inc.

Grade Last Price % Change Price Change
grade C 17.02 3.15% 0.52
SPRB closed up 3.15 percent on Friday, October 23, 2020, on 51 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Up
Historical SPRB trend table...

Date Alert Name Type % Chg
Spinning Top Other 3.15%
Outside Day Range Expansion 3.15%
Up 3 Days in a Row Strength 0.24%
Inside Day Range Contraction 1.25%
Hot IPO Pullback Bullish Swing Setup 4.74%
Inside Day Range Contraction 4.74%
New 52 Week Closing Low Bearish 10.66%
Hot IPO Pullback Bullish Swing Setup 10.66%
New 52 Week Closing Low Bearish 2.53%
Hot IPO Pullback Bullish Swing Setup 2.53%
Older End-of-Day Gignals for SPRB ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Up 5% 2 days ago
Rose Above Previous Day's High 3 days ago
Up 3% 3 days ago
Up 2% 3 days ago
60 Minute Opening Range Breakout 3 days ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company develops tildacerfont, an non-steroidal therapy, which is in Phase IIb clinical trial for adult patients with classic congenital adrenal hyperplasia (CAH) and in Phase II clinical trial in children with classic CAH. It is also developing tildacerfont for females with polycystic ovary syndrome. The company has a license agreement with Eli Lilly and Company to research, develop, and commercialize compounds for various pharmaceutical uses. Spruce Biosciences, Inc. was founded in 2014 and is headquartered in Daly City, California.
Medicine Biopharmaceutical Anatomy Adrenal Gland Disorders Congenital Adrenal Hyperplasia Hyperplasia Classic Congenital Adrenal Hyperplasia Neurocrine Biosciences

Is SPRB a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 18.4894
52 Week Low 15.14
Average Volume 144,273
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 0.00
10-Day Moving Average 16.78
Average True Range 0.00
ADX 0.0
+DI 0.00
-DI 0.00
Chandelier Exit (Long, 3 ATRs ) N/A
Chandelier Exit (Short, 3 ATRs ) N/A
Upper Bollinger Band 0.00
Lower Bollinger Band 0.00
Percent B (%b) 0.0
BandWidth 0.00
MACD Line 0.00
MACD Signal Line 0.00
MACD Histogram 0.0
Fundamentals Value
Market Cap 395.1 Million
Num Shares 23.2 Million
EPS
Price-to-Sales 0.00
Price-to-Book 12.14
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 18.60
Resistance 3 (R3) 18.55 17.99 18.33
Resistance 2 (R2) 17.99 17.59 18.01 18.24
Resistance 1 (R1) 17.50 17.34 17.75 17.55 18.16
Pivot Point 16.94 16.94 17.06 16.96 16.94
Support 1 (S1) 16.45 16.54 16.70 16.50 15.88
Support 2 (S2) 15.89 16.29 15.91 15.80
Support 3 (S3) 15.40 15.89 15.71
Support 4 (S4) 15.45